Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kazia Therapeutics Ltd (NASDAQ:NVGN)

3.17
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.63
Today|||52-Week Range
7.60
-45.90%
Year-to-Date
Institutional investors purchased a net $1.2 thousand shares of NVGN during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 1.57% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional1.57%
Mutual fund holders0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2017MORGAN STANLEY & CO. LLC  Bought 3.2 Thousand shares of Kazia Therapeutics Ltd
9/30/2017UBS SECURITIES LLC  Bought 1.5 Thousand shares of Kazia Therapeutics Ltd
9/30/2017BANK OF AMERICA, NA (PRIVATE BAN...  Bought 146.00 shares of Kazia Therapeutics Ltd

Top 10 Owners of Kazia Therapeutics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Morgan Stanley & Co. LLC0.82%39,500115,538+3,225+8.89%
Renaissance Technologies LLC0.71%34,325100,40100.00%
UBS Securities LLC0.04%1,8325,359+1,525+496.74%
UBS Financial Services, Inc.0.00%208608-1-0.48%
Bank of America, NA (Private Bank...0.00%146427+146--
Marketocracy Capital Management L...0.00%00-200-100.00%
RBC Capital Markets LLC (Investme...0.00%00-1,250-100.00%
Creative Planning, Inc.0.00%00-50-100.00%
Merrill Lynch, Pierce, Fenner & S...0.00%00-55-100.00%
Citadel Advisors LLC0.00%00-4,524-100.00%

Top 10 Mutual Funds Holding Kazia Therapeutics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.00%00-200-100.00%